Anatol Kreitzer insider trades

Open-market stock purchases and sales by Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc, from SEC Form 4 filings since Oct 27, 2025.

Recent trades

DateStockTradeValue
Aug 17, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Aug 17, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Jul 17, 2026MPLT MapLight Therapeutics, IncSold$105K
Jul 17, 2026MPLT MapLight Therapeutics, IncSold$533K
Jul 17, 2026MPLT MapLight Therapeutics, IncSold$7.7K
Jul 16, 2026MPLT MapLight Therapeutics, IncSold$59.6K
Jul 16, 2026MPLT MapLight Therapeutics, IncSold$274K
Jul 15, 2026MPLT MapLight Therapeutics, IncSold$200K
Jul 15, 2026MPLT MapLight Therapeutics, IncSold$167K
Apr 27, 2026MPLT MapLight Therapeutics, IncSold$242K
Apr 27, 2026MPLT MapLight Therapeutics, IncSold$867K
Apr 27, 2026MPLT MapLight Therapeutics, IncSold$239K
Apr 15, 2026MPLT MapLight Therapeutics, IncSold$88.2K
Feb 5, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Feb 5, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Jan 27, 2026MPLT MapLight Therapeutics, IncSold (not open market)$757K
Oct 27, 2025MPLT MapLight Therapeutics, IncBought (not open market)—
Oct 27, 2025MPLT MapLight Therapeutics, IncBought (not open market)—

Companies traded

  • MPLT MapLight Therapeutics, Inc: 11 sales, last Aug 17, 2026

Get free alerts when Anatol Kreitzer files a new trade →